Back to search

National and Kapodistrian University of Athens

Μελέτη πολυμορφικών θέσεων τροποποιητικών γονιδίων σε ασθενείς με χρόνιες πνευμονοπάθειες

Abstract

dc:description

Summary Chronic pulmonary diseases, such as Chronic obstructive pulmonary disease (COPD) and Bronchiectasis are complex diseases influenced by genetic and environmental factors. COPD is characterized by chronic airflow limitation and a range of pathological changes in the lung, some significant extra-pulmonary effects, and important comorbidities, which may contribute to the severity of the disease in individual patients. COPD is a disease state characterized by airflow limitation that is not fully reversible and associated with an abnormal inflammatory response of the lungs to noxious particles or gases. The chronic airflow limitation characteristic of COPD is caused by a mixture of small airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), the relative contributions of which vary from person to person. Bronchiectasis (DB) is characterized by irreversible focal bronchial dilation, usually accompanied by chronic infection and is due to congenital or hereditary conditions. These morphological changes are usually found with chronic suppurative lung disease, which is characterized by productive cough and purulent sputum expectoration. Bronchiectasis may be focal and limited to a single segment or lobe or it may be widespread and affect multiple lobes in one or both lungs. The present is an association study aiming to investigate the genetic contribution of polymorphisms/ mutations in different genes on the pathogenesis of COPD and DB. Additionally we sought to develop an advanced high throughout methodology for SNP/mutation identification, amenable to automation. The patient groups consisted of 117 stable COPD patients and 62 patients with DB both of Greek origin. The control groups consisted of 109 current asymptomatic and ex smokers but without evidence of COPD or other lung disease and a general population control group (n=212). Whole blood samples from the two patient groups and the asymptomatic smokers were obtained from the COPD Outpatient Clinic of the Respiratory Department of the University of Athens at “Sotiria” Hospital. And the general population control group came from the Department of Medical Genetics of the Medical School of the University of Athens. The TNF-a, SERPINA1 and ADRB2 genes were studied. The results have shown that a TNF-a diplotype could be a risk factor for COPD. While no association was discovered between the mutations/ polymorphisms in the SERPINA1 and ADRB2 genes and COPD, we found that the normal homozygous SERPINA1 p.Val213Val genotype was less prevalent in DB patients than in healthy smokers, which suggested that the p.Ala213 variant may play a role in the pathogenesis of DB. We also showed a significant association between the Gly16 ADRB2 polymorphism and the severity of COPD, which was represented by values for FEV1 percent, predicted. Finally, our study contributed to the standardization of the DNA microarray methodology, which can be used for further analysis of polymorphisms/ mutations in other genes.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Παπαθεοδώρου, Αθανάσιος
  • Papatheodorou, Athanasios

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27452

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Παπαθεοδώρου, Αθανάσιος; Papatheodorou, Athanasios. Μελέτη πολυμορφικών θέσεων τροποποιητικών γονιδίων σε ασθενείς με χρόνιες πνευμονοπάθειες. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/27452